Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones

International Journal of Cancer

Volumn 66, Issue 6, 1996, Pages 802-805

  Azuma, Masayuki ^a   Yuki, Tokuyuki ^a   Tamatani, Tetsuya ^a   Motegi, Katsumi ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL CLONE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND CANCER; SALIVARY GLAND DUCT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TRANSFORMED; CLONE CELLS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SALIVARY DUCTS; SALIVARY GLAND NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030005435     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960611)66:6<802::AID-IJC16>3.0.CO;2-4     Document Type: Article

References (22)

1. AZUMA, M., KASAI, Y., TAMATANI, T. and SATO, M., Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett., 65, 61-71 (1992).
2. AZUMA, M., TAMATANI, T., FUKUI, K., YOSHIDA, H., KAMOGASHIRA, T., OGINO, K., SUZUKI, T. and SATO, M., Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells. Int. J. Cancer, 54, 669-676 (1993a).
3. - mutant DNA. Lab. Invest., 69, 24-42 (1993b).
4. BASSING, G.H., HOWE, D.J., SEGARINI, P.R., DONAHOE, P.K. and WANG, X.-F., A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J. biol. Chem., 269, 14861-14864 (1994).
5. CÁRCAMO, J., WEIS, F.M.B., VENTURA, F., WIESER, R., WRANA, J.L., AITISANO, L. and MASSAGUÉ, J., Type I receptors specify growth inhibitory and transcriptional responses to TGFβ and activin. Mol. cell. Biol., 14, 3810-3821 (1994).
6. CHEN, R.-H., EBNER, R. and DERYNCK, R., Inactivation of the type-II receptor reveals two receptor pathways for the diverse TGF-β activities. Science, 260, 1335-1338 (1993).
7. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
8. FEINBERG, A.P. and VOGELSTEIN, B., A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137, 266-267 (1984).
9. FRANZÉN, P., TEN DUKE, P., ICHIJO, H., YAMASHITA, H., SCHULZ, P., HLLDIN, C.H. and MIYAZONO, K., Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75, 681-692 (1993).
10. ICHIJO, H., MOMOSE, F. and MIYAZONO, K., Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells. Exp. Cell Res., 187, 263-269 (1990).
11. LAUMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
12. LAIHO, M., DECAPRIO, J.A., LUDLOW, J.W., LIVINGSTONl, D.M. and MASSAGUE, J., Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell. 62, 175-185 (1990).
13. LAIHO, M., RONNSTRAND, L., HEINO, J., DECAPRIO, J.A., LUDLOW, J.W., LIVINGSTON, D.M. and MASSAGUE, J., Control of junB and extracellular matrix protein expression by transforming growth factor-β1 is independent of simian virus 40 T antigen-sensitive growth-inhibitory events. Mol. cell. Biol., 11, 972-978 (1991).
14. LIN, H.Y., WANG, X.-F., NG-EATON, E., WEINBERG, R.A. and LODISH, H.F., Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785 (1992).
15. LOPEZ-CASILLAS, F., WRANA, J.L. and MASSAGUÉ, J., Betaglycan presents ligand to the TGFβ signalling receptor. Cell, 73, 1435-1444 (1993).
16. MARKOWITZ, S., WANG, J., MYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILLSON, J.K.V., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268, 1336-1338 (1995).
17. MOGI, Y., KATO, J., HORIMOTO, M., TAKIMOTO, R., MURAKAMI, T., HIRAYAMA, A., KOHGO, Y., WATANABE, N. and NHTSU, Y., Close correlation between the dephosphorylation of p53 and growth suppression by transforming growth factor-β1 in nasopharyngeal carcinoma cells transduced with adenovirus early genes. Jpn. J. Cancer Res., 85, 459-463 (1994).
18. MOSES, H.L., TGF-β regulation of epithelial cell proliferation. Mol. Reprod. Develop., 32, 179-184 (1992).
19. PARK. K., KIM, S.-J., BANG, Y.-J., PARK, J.-G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc nat. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
20. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular cloning, a laboratory manual (2nd ed.), Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY (1989).
21. SATO, M., YOSHIDA, H., HAYASHI, Y., MIYAKAMI, K., BANDO, T., YANAGAWA, T., YURA, Y., AZUMA, M. and UENO, A., Expression of epidermal growth factor and transforming growth factor-β in a human salivary gland adenocarcinoma cell line. Cancer Res., 45, 6160-6167 (1985).
22. STENMAN, G., MARK, J. and EKEDAHL, C., Relationships between chromosomal patterns and protooncogenes in human benign mixed salivary gland tumors. Tumor Biol., 5, 103-117 (1984).